128 related articles for article (PubMed ID: 10525661)
21. Defective trafficking and function of KATP channels caused by a sulfonylurea receptor 1 mutation associated with persistent hyperinsulinemic hypoglycemia of infancy.
Cartier EA; Conti LR; Vandenberg CA; Shyng SL
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2882-7. PubMed ID: 11226335
[TBL] [Abstract][Full Text] [Related]
22. Differential nucleotide regulation of KATP channels by SUR1 and SUR2A.
Masia R; Enkvetchakul D; Nichols CG
J Mol Cell Cardiol; 2005 Sep; 39(3):491-501. PubMed ID: 15893323
[TBL] [Abstract][Full Text] [Related]
23. Effects of Troglitazone (CS-045) on insulin secretion in isolated rat pancreatic islets and HIT cells: an insulinotropic mechanism distinct from glibenclamide.
Masuda K; Okamoto Y; Tsuura Y; Kato S; Miura T; Tsuda K; Horikoshi H; Ishida H; Seino Y
Diabetologia; 1995 Jan; 38(1):24-30. PubMed ID: 7744225
[TBL] [Abstract][Full Text] [Related]
24. 2-(4-Methoxyphenoxy)-5-nitro-N-(4-sulfamoylphenyl)benzamide activates Kir6.2/SUR1 K(ATP) channels.
Nielsen FE; Jacobsen P; Worsaae A; Arkhammar PO; Wahl P; Bondo Hansen J
Bioorg Med Chem Lett; 2004 Dec; 14(23):5727-30. PubMed ID: 15501029
[TBL] [Abstract][Full Text] [Related]
25. Structural requirements of sulphonylureas and analogues for interaction with sulphonylurea receptor subtypes.
Meyer M; Chudziak F; Schwanstecher C; Schwanstecher M; Panten U
Br J Pharmacol; 1999 Sep; 128(1):27-34. PubMed ID: 10498831
[TBL] [Abstract][Full Text] [Related]
26. cAMP-activated protein kinase-independent potentiation of insulin secretion by cAMP is impaired in SUR1 null islets.
Nakazaki M; Crane A; Hu M; Seghers V; Ullrich S; Aguilar-Bryan L; Bryan J
Diabetes; 2002 Dec; 51(12):3440-9. PubMed ID: 12453898
[TBL] [Abstract][Full Text] [Related]
27. A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes.
Proks P; Arnold AL; Bruining J; Girard C; Flanagan SE; Larkin B; Colclough K; Hattersley AT; Ashcroft FM; Ellard S
Hum Mol Genet; 2006 Jun; 15(11):1793-800. PubMed ID: 16613899
[TBL] [Abstract][Full Text] [Related]
28. ATP-sensitive K+ channels: regulation of bursting by the sulphonylurea receptor, PIP2 and regions of Kir6.2.
Ribalet B; John SA; Xie LH; Weiss JN
J Physiol; 2006 Mar; 571(Pt 2):303-17. PubMed ID: 16373383
[TBL] [Abstract][Full Text] [Related]
29. Sensitivity of Kir6.2-SUR1 currents, in the absence and presence of sodium azide, to the K(ATP) channel inhibitors, ciclazindol and englitazone.
McKay NG; Kinsella JM; Campbell CM; Ashford ML
Br J Pharmacol; 2000 Jun; 130(4):857-66. PubMed ID: 10864893
[TBL] [Abstract][Full Text] [Related]
30. Transgenic overexpression of SUR1 in the heart suppresses sarcolemmal K(ATP).
Flagg TP; Remedi MS; Masia R; Gomes J; McLerie M; Lopatin AN; Nichols CG
J Mol Cell Cardiol; 2005 Oct; 39(4):647-56. PubMed ID: 16099470
[TBL] [Abstract][Full Text] [Related]
31. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.
Schwanstecher M; Sieverding C; Dörschner H; Gross I; Aguilar-Bryan L; Schwanstecher C; Bryan J
EMBO J; 1998 Oct; 17(19):5529-35. PubMed ID: 9755153
[TBL] [Abstract][Full Text] [Related]
32. The insulin secretory granule is the major site of K(ATP) channels of the endocrine pancreas.
Geng X; Li L; Watkins S; Robbins PD; Drain P
Diabetes; 2003 Mar; 52(3):767-76. PubMed ID: 12606519
[TBL] [Abstract][Full Text] [Related]
33. Differential interactions of nateglinide and repaglinide on the human beta-cell sulphonylurea receptor 1.
Hansen AM; Christensen IT; Hansen JB; Carr RD; Ashcroft FM; Wahl P
Diabetes; 2002 Sep; 51(9):2789-95. PubMed ID: 12196472
[TBL] [Abstract][Full Text] [Related]
34. Different molecular sites of action for the KATP channel inhibitors, PNU-99963 and PNU-37883A.
Cui Y; Tinker A; Clapp LH
Br J Pharmacol; 2003 May; 139(1):122-8. PubMed ID: 12746230
[TBL] [Abstract][Full Text] [Related]
35. Sulfonylurea receptors and ATP-sensitive K+ channels in clonal pancreatic alpha cells. Evidence for two high affinity sulfonylurea receptors.
Rajan AS; Aguilar-Bryan L; Nelson DA; Nichols CG; Wechsler SW; Lechago J; Bryan J
J Biol Chem; 1993 Jul; 268(20):15221-8. PubMed ID: 8325894
[TBL] [Abstract][Full Text] [Related]
36. Characterization of low-affinity binding sites for glibenclamide on the Kir6.2 subunit of the beta-cell KATP channel.
Gros L; Virsolvy A; Salazar G; Bataille D; Blache P
Biochem Biophys Res Commun; 1999 Apr; 257(3):766-70. PubMed ID: 10208857
[TBL] [Abstract][Full Text] [Related]
37. Testing the bipartite model of the sulfonylurea receptor binding site: binding of A-, B-, and A + B-site ligands.
Winkler M; Stephan D; Bieger S; Kühner P; Wolff F; Quast U
J Pharmacol Exp Ther; 2007 Aug; 322(2):701-8. PubMed ID: 17495126
[TBL] [Abstract][Full Text] [Related]
38. Antisense oligodeoxynucleotides of sulfonylurea receptors inhibit ATP-sensitive K+ channels in cultured neonatal rat ventricular cells.
Yokoshiki H; Sunagawa M; Seki T; Sperelakis N
Pflugers Arch; 1999 Feb; 437(3):400-8. PubMed ID: 9914396
[TBL] [Abstract][Full Text] [Related]
39. Intracellular ATP-sensitive K+ channels in mouse pancreatic beta cells: against a role in organelle cation homeostasis.
Varadi A; Grant A; McCormack M; Nicolson T; Magistri M; Mitchell KJ; Halestrap AP; Yuan H; Schwappach B; Rutter GA
Diabetologia; 2006 Jul; 49(7):1567-77. PubMed ID: 16752175
[TBL] [Abstract][Full Text] [Related]
40. Role of sulfonylurea receptor type 1 subunits of ATP-sensitive potassium channels in myocardial ischemia/reperfusion injury.
Elrod JW; Harrell M; Flagg TP; Gundewar S; Magnuson MA; Nichols CG; Coetzee WA; Lefer DJ
Circulation; 2008 Mar; 117(11):1405-13. PubMed ID: 18316485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]